Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Clinical trial NCT03737123 · TERMINATED
Trial details
- NCT number
- NCT03737123
- Sponsor
- Nabil Adra
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2022-03-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.